Nutriband Inc. Ties Shareholder Rewards to FDA Approval Milestone with 25% Preferred Stock Dividend
Nutriband Inc. (NASDAQ: NTRB) has announced a 25% preferred stock dividend, linking shareholder rewards directly to the FDA approval process for its lead product, AVERSA(TM) Fentanyl, highlighting the significance of regulatory achievements in biopharmaceutical value creation.
